Articles On ImpediMed (ASX:IPD)

ImpediMed makes leadership and board changes to enhance growth and manage costs effectively Rick Valencia will step down from his role as Managing Director and CEO effective immediately Dr. Parmjot Bains takes on the role of Interim C...

At the $240 million Perennial Better Future Trust, healthcare stocks are a critical component of our ESG-focused portfolio. These stocks, many of which have global reach, have the potential to generate attractive returns while shaping a bet...

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...

The Australian stock market has surged around midday, buoyed by the positive performance on Wall Street, amid growing optimism that the Federal Reserve might have concluded its series of interest rate hikes. At noon, the S&P/ASX 200 is...

  To register for today's webinar click here. Findi (ASX:FND) has extended the existing State Bank of India contract until 30 September 2024. Commenting on the SBI contract extension, Findi Chairman Mr Nicholas Smedley said: “The SBI contra...

03 Nov 2023 - A snapshot of the stocks on the move, featuring Findi (ASX:FND), Immutep (ASX:IMM) and ImpediMed (ASX:IPD).

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

Bod Science confirm the effectiveness of Aqua Phase technology ImpediMed announces new chief medical officer   Bod Science set to commercialise Aqua Phase Cannabis focused biotech, Bod Science (ASX:BOD), surged 12% this morning after prov...

2023 a case of “haves and have nots” for ASX biotech sector as companies with good catalysts lead the pack  Neuren’s results of Phase 2 clinical trial of NNZ-2591 in Phelan-McDermid syndrome due in December Antisense Therapeutics Phase2b t...

Polynovo Ltd (ASX: PNV) shares have struggled to find support in 2023. After a brief reprieve between May and August, the wound treatment company has seen its share price slapped with a 22.3% decline over the last 29 days. On Friday, shar...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIS)) - Aeris Resources ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((ATA)) - Atturra ((AUA)) - Audeara ((ASB)) - Austal ((BUB)) - Bubs Australia ((CCX))...

ASX healthcare stocks haven’t done so well as a collective over the past 12 months. The S&P/ASX 200 Health Care Index (ASX: XHJ) is down 8% over the past year. By comparison, the market benchmark S&P/ASX 200 Index (ASX: XJO) is u...

US healthcare company, CurveBeam AI, is preparing to debut on the ASX today after concluding its pre-initial public offering (IPO) private placement of $25 million. CurveBeam will be listed under the ticker code ‘CVB,’ providing investor...

ASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes more than 50% after US FDA rejects a key product  ImpediMed falls after calls for board spill with discontent following cap raise Healthcare...

World Overnight SPI Overnight 7360.00 – 39.00 – 0.53% S&P ASX 200 7450.70 + 40.30 0.54% S&P500 4576.73 – 12.23 – 0.27% Nasdaq Comp 14283.91 – 62.11 – 0.43% DJIA 35630.68 + 71.15 0.20% S&P500 VIX 13.93 + 0.30 2.20%...

World Overnight SPI Overnight 7383.00 + 25.00 0.34% S&P ASX 200 7410.40 + 6.80 0.09% S&P500 4588.96 + 6.73 0.15% Nasdaq Comp 14346.02 + 29.37 0.21% DJIA 35559.53 + 100.24 0.28% S&P500 VIX 13.63 + 0.30 2.25% US 10...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

The S&P/ASX 200 Index (ASX: XJO) is on form again and on track to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,340 points. Four ASX shares that have failed to follow the market higher today are listed...

The Energy sector demonstrated strong growth, with a rally of 1.7%. Ampol (ASX:ALD) experienced a significant surge of 4.4% following robust fuel sale volumes reported for the first half of the financial year 2023. Woodside Petroleum (ASX:W...

Woodside Energy (ASX:WPL), reported a 29% decline in revenue for the second quarter, amounting to $US3.1 billion (A$4.5 billion). Sales of oil decreased by 4%, with 48.4 million barrels sold, while production experienced a 5% drop to 44.5 m...

  ImpediMed (ASX:IPD) are the first top 5 national payor covering SOZO testing for cancer patients at risk for lymphoedema. In response, CEO and MD Richard Valencia said, ”Cigna’s policy provides access to coverage for all individuals at ri...

19 Jul 2023 - A snapshot of the stocks on the move, featuring ImpediMed (ASX:IPD), Imugene Limited (ASX:IMU) and Brightstar Resources (ASX:BTR).

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

World Overnight SPI Overnight 7182.00 – 37.00 – 0.51% S&P ASX 200 7253.20 – 25.80 – 0.35% S&P500 4446.82 – 8.77 – 0.20% Nasdaq Comp 13791.65 – 25.12 – 0.18% DJIA 34288.64 – 129.83 – 0.38% S&P500 VIX 14.18 + 0.48 3....

World Overnight SPI Overnight 7233.00 – 12.00 – 0.17% S&P ASX 200 7279.00 + 32.90 0.45% S&P500 4455.59 Nasdaq Comp 13816.77 DJIA 34418.47 S&P500 VIX 13.70 US 10-year yield 3.86 USD Index 103.08 + 0.09...

World Overnight SPI Overnight 7216.00 – 1.00 – 0.01% S&P ASX 200 7246.10 + 42.80 0.59% S&P500 4455.59 + 5.21 0.12% Nasdaq Comp 13816.77 + 28.85 0.21% DJIA 34418.47 + 10.87 0.03% S&P500 VIX 13.57 – 0.02 – 0.15% US...

Clinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsay releases several announcements this week including possible sale of joint Asian venture Mach 7 expects significant cash collections in Q4...

ShareCafeMiners surge on higher iron ore prices: ASX closes up 1% by Peter Milios   At the closing bell, the S&P/ASX 200 was 1.00 per cent higher at 7,216.30. The increase was driven by the mining and consumer discretionary sectors, whi...

ShareCafeAustralia’s inventories increase for March Qtr: ASX 1.05% higher at noon by Peter Milios   In the March quarter, Australia’s inventories increased by 1.2 per cent compared to the previous quarter, surpassing Bloomberg’s predicted 0...

ShareCafeStocks of the Hour: REZ, WA1, IPD                    Resources & Energy Group (ASX:REZ) announced that their opening drilling campaign has confirmed nickel sulphides at their Springfield Nickel Prospect in WA. MD and CEO,...

05 Jun 2023 - A snapshot of the stocks on the move featuring Resources & Energy Group (ASX:REZ), WA1 Resources (ASX:WA1) and ImpediMed (ASX:IPD).

ASX health stocks outperforming the broader market but remain flattish for week Several ASX health plays undertaking capital raising with more expected in H2 CY23 Micro-X successfully tests its Argus bomb detection unit opening door to US$...

The market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts that will push this momentum further? ASX biotechs that announced FDA breakthroughs this year   After a challenging 2022, we are finally s...

ASX health stocks have fallen in the past five days in line with broader markets Volpara Health Technologies reports strong FY23 results, above Morgan’s expectations Pharmaxis reports positive trial results in potential breakthrough treatm...

EBR announces positive results of its pivotal SOLVE-CRT trial at Heart Rhythm 2023 in US EBR latest ASX biotech company to achieve a key catalyst, opening door to US$2.5 billion market Company now working on regulatory and commercialisatio...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.6% to 7,278.9 points. Four ASX shares that have failed to follow the market high...

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

The Brisbane-headquartered medtech is drumming up interest in a $20 million placement, cashing in on the changes to cancer care guidelines in the US.

ASX health stocks rise in the past five days outperforming broader markets Avita Medical product sales up 40% on pcp to US$10.5 million in Q1 FY23 Proteomics International Laboratories inks a deal with Sonic Healthcare USA Healthcare and...

ShareCafeASX closes 0.4% higher as US futures rise by Peter Milios   The S&P/ASX 200 index finished 0.4 per cent higher at 7,220 points as a result of the rise in US futures due to Apple’s better-than-expected results. This gain in the...

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

ShareCafeResults from Macquarie & ANZ: ASX 0.11% higher by Peter Milios   At noon, the S&P/ASX 200 is 0.11 per cent higher at 7,200.80. Macquarie Group (ASX:MQG) reported a record profit of $5.18 billion for the year ending March 31...

ShareCafeStocks of the Hour: SPT, IPD, MGT                    Splitit Payments (ASX:SPT, OTCQX:SPTTY), announces it has signed a new two-year partnership agreement with Visa. Through this collaboration, participating acquirers and mer...

05 May 2023 - A snapshot of the stocks on the move featuring Splitit Payments (ASX:SPT), ImpediMed Limited (ASX:IPD) and Magnetite Mines (ASX:MGT).

ImpediMed gets clearance from the US FDA for its SOZO Pro bioimpedance spectroscopy SOZO Pro offers a new, higher standing weight capacity compared to SOZO Incannex’s subsidiary to open a clinic to provide psychedelic-assisted psychotherap...

The ASX is set to extend losses on banking crisis concerns Shares in regional banks PacWest and Western Alliance collapsed The ECB raised its key rate by 25bp   The ASX is poised to extend its losses on Friday following another selloff in...

The ASX is expected to fall on Friday on further fears surrounding the global banking sector — US bank stocks continue to tumble, dragging Wall Street down. Here are some ASX-listed companies to look out for on Friday: Splitit Payment...

ASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners again, up 1.96% and well ahead of the market Mt Monger does well with a 23% gain to be over +130% for the month   After an early grimace-indu...

ASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% after BIS tech named in latest US NCCN guidelines for lymphoedema  EBR Systems to release top line results at cardiac conference Heart Rhythm...

ShareCafeASX closes flat despite rise in US futures by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.10 per cent higher at 6,962, and closed almost unchanged despite a rise in US futures. The index ended up 0.1 per cent at 6...